A study found that using the digital therapeutic app MyCognition can ease perception of cognitive decline in breast cancer patients.
Around 75% of breast cancer patients report experiencing cognitive decline known as ‘chemo brain’ during or after treatment, according to research.
In a clinical trial at the University of Antwerp, between 2016 and 2020, experts investigated whether the app...
